MedTrace Logo

Preoperative Chemoradiotheray for Rectal Cancer

NCT00819559 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1160

Last updated 2009-01-12

No results posted yet for this study

Summary

Hypothesis

* Pre operative radio-chemotherapy might be not mandatory to improve local recurrent rate and survival rate in the mid-lower rectal cancer patients with T3N0 clinical stage, if surgical principals were kept.
* Laparoscopic resection is not inferior to Open surgery in the treatment of rectal cancer.

Conditions

  • Rectal Neoplasm

Interventions

RADIATION

PCRT

Preoperative chemoradiotherapy

Sponsors & Collaborators

  • Korean Rectal Cancer Study Group

    lead NETWORK

Principal Investigators

  • Gyu-Seog Choi, M.D. · School of Medicine, Kyungpook National University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2011-02-28
Completion
2016-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00819559 on ClinicalTrials.gov